Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:27 PM
Ignite Modification Date:
2025-12-24 @ 9:27 PM
NCT ID:
NCT01932632
Eligibility Criteria:
Inclusion Criteria:
* age\>70
* Living in one of the 6 participating residential care facilities:
1. Youville Residence, PHC, 4950 Heather Street, Vancouver, BC, V5Z 3L9
2. Brock Fahrni Residence, 4650 Oak Street, Vancouver, BC, V6H 4J4
3. Mount St. Joseph's LTC, PHC, 3080 Prince Edward Street, Vancouver, BC, V5T 3N4
4. Holy Family Hospital, PHC, 7801 Argyle Street, Vancouver, BC, V5P 3L6
5. St. Vincent's Langara, PHC, 255 West 62nd Avenue, BC, V5X 4V4
6. Minoru Residence, VCH, 6111 Minoru Boulevard, Richmond, BC V6Y 1Y4
* Attending GP has agreed to participate in study
* Taking more that 5 medications
* If unable to provide consent (due to cognitive impairment, aphasia or any other barrier), that there is a family member or designated decision maker able and willing to sign consent
1. Cognitive impairment will be identified by the attending GP. Any participant who is deemed unable to consent as a result of cognitive impairment will be offered a chance to participate by the research team contacting the alternate decision maker identified in the patient's chart. If appropriate, an assent form will be made available to those participants who agree to sign the consent form for their loved one
Exclusion Criteria:
* On hemodialysis (due to multiple active prescribing MD's at anyone time)
* If cognitively impaired, but family member, (or designated decision maker) cannot be contacted to discuss and sign consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT01932632
Study Brief:
Protocol Section:
NCT01932632